Common Contracts

Dr. Reddy's and Pharmazz, Inc. enter into licensing agreement to market first- in-class Centhaquine (Lyfaquin®) for hypovolemic shock in India

Licensing Agreement • March 22nd, 2024

• Contract Type
  Licensing Agreement
• Filed
  March 22nd, 2024

• Centhaquine is a first-of-its-kind resuscitative agent to treat hypovolemic shock by increasing stroke volume and cardiac output due to an increase in (preload) venous blood return to the heart and a decrease in (afterload) due to arterial dilatation